Search clinical trials for: Aclacinomycin, Cytarabine
Total 1237 results
-
Jianxiang WangUnknownAcute Myeloid LeukemiaChina
-
The First Hospital of Jilin UniversitySecond Hospital of Jilin University; The Second Affiliated Hospital of Dalian... and other collaboratorsActive, not recruitingAcute Myeloid LeukemiaChina
-
Chinese PLA General HospitalNavy General Hospital, BeijingCompleted
-
Chinese PLA General HospitalThe General Hospital of Western Theater Command; First Hospital of China Medical... and other collaboratorsRecruitingAcute Myeloid LeukemiaChina
-
Hematology department of the 920th hospitalRecruitingRefractory/Relapse Acute Myeloid LeukemiaChina
-
Sun Yat-sen UniversityUnknownAcute Myeloid Leukemia | Relapse LeukemiaChina
-
Chinese PLA General HospitalThe General Hospital of Western Theater Command; First Hospital of China Medical... and other collaboratorsRecruitingRelapsed/Refractory Acute Myeloid LeukemiaChina
-
Chinese PLA General HospitalNavy General Hospital, BeijingCompleted
-
The First Affiliated Hospital of Soochow UniversityNot yet recruitingRelapsed/Refractory AMLChina
-
Washington University School of MedicineCompletedVasculopathy, Retinal, With Cerebral Leukodystrophy | Cerebroretinal Vasculopathy, HereditaryUnited States
-
Shanxi Bethune HospitalAntengene CorporationRecruitingRelapsed or Refractory Acute Myeloid LeukemiaChina
-
Institute of Hematology & Blood Diseases HospitalRecruitingAcute Myeloid LeukemiaChina
-
Fred Hutchinson Cancer CenterJazz PharmaceuticalsRecruitingAcute Myeloid Leukemia | Myeloid NeoplasmUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Chronic Myelomonocytic Leukemia | Refractory Chronic Myelomonocytic Leukemia | Blasts More Than 5 Percent of Bone Marrow Nucleated Cells | Recurrent High Risk Myelodysplastic Syndrome | Refractory High Risk Myelodysplastic Syndrome | Blasts 10-19 Percent of Bone Marrow Nucleated Cells and other conditionsUnited States
-
Sunesis PharmaceuticalsCompletedAcute Myeloid LeukemiaUnited States, Canada, Spain, Belgium, Korea, Republic of, Australia, France, Germany, Poland, New Zealand, United Kingdom, Czechia, Austria, Hungary, Italy
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)RecruitingRefractory Acute Myeloid Leukemia | Blasts More Than 5 Percent of Bone Marrow Nucleated Cells | Persistent DiseaseUnited States
-
Fred Hutchinson Cancer CenterJazz PharmaceuticalsTerminatedAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2 | Myeloid NeoplasmUnited States
-
Roswell Park Cancer InstituteJazz PharmaceuticalsRecruitingAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Acute Myeloid Leukemia With Myelodysplasia-Related ChangesUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Secondary Acute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterRecruitingMyelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Myeloproliferative Neoplasm | Acute Myeloid Leukemia With Gene MutationsUnited States
-
M.D. Anderson Cancer CenterRecruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Institute of Hematology & Blood Diseases Hospital...Recruiting
-
National Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Acute Myeloid Leukemia With Multilineage Dysplasia | Acute Myeloid Leukemia Post Cytotoxic TherapyUnited States
-
M.D. Anderson Cancer CenterRecruitingAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Cornerstone PharmaceuticalsTerminatedRelapsed/Refractory Acute Myeloid LeukemiaUnited States, Spain, Korea, Republic of, France, Australia, Belgium, Austria, Germany, Poland
-
Beijing 302 HospitalNot yet recruitingRefractory Acute Myeloid Leukemia | Minimal Residual Disease | Relapsed Acute Myeloid Leukemia
-
Baylor Research InstituteCompletedMyelodysplastic Syndromes | Acute Myelogenous Leukemia | Chronic Myelogenous LeukemiaUnited States
-
Wake Forest University Health SciencesTerminated
-
Janssen Research & Development, LLCTerminatedAcute Myeloid LeukemiaFrance, United Kingdom, Spain, Belgium, Netherlands, Germany, Denmark
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | Blasts More Than 10 Percent of Bone Marrow Nucleated CellsUnited States
-
Weill Medical College of Cornell UniversityTerminatedAcute Myeloid Leukemia (AML)United States
-
French Innovative Leukemia OrganisationRecruiting
-
BioSight Ltd.CompletedAcute Myeloid Leukemia | Acute Lymphoblastic LeukemiaIsrael
-
Ohio State University Comprehensive Cancer CenterIncyte Corporation; Jazz PharmaceuticalsRecruitingPolycythemia Vera | Essential Thrombocythemia | Myelofibrosis | Secondary Acute Myeloid Leukemia | Myeloproliferative NeoplasmUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Withdrawn
-
Pacira Pharmaceuticals, IncUnknownLymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Leukemia | Brain and Central Nervous System TumorsCanada, United States
-
Antisoma ResearchUnknownSecondary Acute Myeloid Leukemia (Secondary AML, sAML)Korea, Republic of, United States, Spain, United Kingdom, Australia, Austria, Taiwan, Israel, Italy, Belgium, Germany, France, Romania, Estonia, Canada, Ukraine, Ecuador, Hungary, Poland, Chile, Argentina, Czech Republic, Russian Federation
-
NCIC Clinical Trials GroupBayerCompletedMyelodysplastic Syndromes | LeukemiaCanada
-
National Center for Research Resources (NCRR)University of MichiganCompletedLupus Erythematosus, Systemic
-
Vion PharmaceuticalsCompletedLeukemiaFrance, Canada, Greece, United States, Belgium, Netherlands, United Kingdom, Germany, Poland, Serbia
-
Philogen S.p.A.Terminated
-
National Cancer Institute, NaplesIRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; Santobono-Pausilpon...Active, not recruitingAcute Lymphoblastic LeukemiaItaly
-
Hoffmann-La RocheCompletedMyelogenous Leukemia, AcuteFrance, Germany, Italy
-
Hoffmann-La RocheCompletedMyelogenous Leukemia, AcuteCanada, United States, United Kingdom, France, Italy
-
Vion PharmaceuticalsUnknownLeukemiaFrance, United States, United Kingdom
-
Vion PharmaceuticalsCompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Technische Universität DresdenCompletedLeukemia, Nonlymphoblastic, AcuteGermany
-
Cooperative Study Group A for HematologyUnknownAcute Myelogenous LeukemiaKorea, Republic of
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Drug/Agent Toxicity by Tissue/OrganUnited States
-
Vion PharmaceuticalsNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States